期刊文献+

宽胸理肺汤合三子养亲汤治疗老年慢性阻塞性肺疾病急性加重期痰浊壅肺证的临床疗效 被引量:10

Clinical curative effect of Kuanxiong Lifei decoction combined with Sanzi Yangqin decoction in the treatment of elderly patients with chronic obstructive pulmonary disease with acute exacerbation of Tanzhuo Yongfei
下载PDF
导出
摘要 目的:探讨宽胸理肺汤合三子养亲汤治疗老年慢性阻塞性肺疾病急性加重期痰浊壅肺证的临床疗效。方法:收治患者60例,随机分为观察组、宽胸理肺汤组和对照组各20例,对照组采用常规西药治疗,宽胸理肺汤组在对照组的基础之上加用宽胸理肺汤,观察组在宽胸理肺汤组基础之上加用三子养亲汤,比较3组治疗效果。结果:对照组、宽胸理肺汤组、观察组的总有效率依次为25%、75%、85%,对照组和观察组治疗效果差异有统计学意义(P<0.05)。结论:宽胸理肺汤合三子养亲汤治疗老年慢性阻塞性肺疾病急性加重期痰浊壅肺证的临床疗效显著。 Objective:To explore the clinical curative effect of Kuanxiong Lifei Decoction combined with Sanzi Yangqin decoctionin the treatment of elderly patients with chronic obstructive pulmonary disease with acute exacerbation of Tanzhuo Yongfei.Methods:60 cases of patients were selected.They were were randomly divided into the observation group and the Kuanxiong Lifeidecoction group and the control group with 20 cases in each group.The control group was treated with routine western medicine.The Kuanxiong Lifei decoction group was treated with Kuanxiong Lifei decoction on the basis of the control group.The observationgroup was treated with Sanzi Yangqin decoction on the basis of the Kuanxiong Lifei decoction group.We compared the therapeuticeffect of three groups.Results:The total effective rate of the control group,Kuanxiong Lifei decoction group and the observationgroup was 25%,75%,85% respectively,and there were significant differences in clinical curative effect between the control groupand the observation group(P<0.05).Conclusion:The clinical curative effect of Kuanxiong Lifei decoction combined with SanziYangqin decoction in the treatment of elderly patients with chronic obstructive pulmonary disease with acute exacerbation ofTanzhuo Yongfei was significant.
作者 文超 Wen Chao(Emergency Department,the Traditional Chinese Medicine Hospital of Zhenxiong County,Zhaotong City,Yunnan Province 657200)
出处 《中国社区医师》 2016年第18期102-102,104,共2页 Chinese Community Doctors
关键词 宽胸理肺汤 三子养亲汤 老年慢性阻塞性肺疾病 中西医疗法 Kuanxiong Lifei decoction Sanzi Yangqin decoction Elderly patients with chronic obstructive pulmonary disease Chinese and western medical treatment
  • 相关文献

参考文献2

二级参考文献27

  • 1方邦江,占鸽.宽胸理肺汤治疗慢性肺心病64例[J].陕西中医,1994,15(4):150-150. 被引量:5
  • 2中华人民共和国卫生部主编.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002:127-128.
  • 3Agusti A.Systemic effects of chronic obstructive pulmonary disease:what we know and what we don’t know(but should)[J].Proc Am Thorac Soc,2007,4(7):522-525.
  • 4Celli BR,Locantore N,Yates J,et al.Inflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary disease[J].Am J Respir Crit Care med,2012,185(10):1065-1072.
  • 5The Global Initiative for Chronic Obstructive Disease Science Committee.Global strategy for the diagnosis management and prevention of chronic obstructive pulmonary disease(2013)[EB/OL].http://www.goldcopd.org/Global Initiative for Chronic Obstructive Lung Disease.
  • 6De Serres G,Lampron N,La Forge J,et al.Importance of viral and bacterial infections in chronic obstructive pulmonary disease exacerbations[J].J Clin Virol,2009,46(2):129-133.
  • 7Wise RA.The value of forced expiratory volume in 1 second decline in the assessment of chronic obstructive pulmonary disease progression[J].Am J Med,2006,119(10A):4-11.
  • 8Wedzicha JA.The heterogeneity of chronic obstructive pulmonary disease[J].Thorax,2000,55(12):631-632.
  • 9曾勉,刘凌云,王辉,关开泮,贺云鹏,严英硕,谢灿茂.慢性阻塞性肺疾病患者痰中TNF-α及其受体水平与气流受限的关系[J].中山大学学报(医学科学版),2008,29(1):82-86. 被引量:6
  • 10李倩,粟毅.中性粒细胞在慢性阻塞性肺疾病发病中的作用[J].新医学,2010,41(5):348-350. 被引量:12

共引文献56

同被引文献60

引证文献10

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部